NEW YORK, NY / ACCESS Newswire / September 5, 2025 / SueWallSt: Class Action Filed Against iRobot Corporation – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between January 29, 2024 and March 11, 2025. If you suffered a […]
Trading resumes in: Company: Sol Strategies Inc. CSE Symbol: HODL All Issues: No Resumption (ET): 2:34:27 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which
Introducing ThePlano Suede and the Marco Goat Tony Lama Boots is proud to announce a major expansion of its Men's Derby Collection with six new 12-inch cowboy boots that elevate the brand's modern Western offering. Featuring the Plano Suede boots in three new colors and the Marco Goat boots in three new colors, this release
Every five minutes, someone in the United States is diagnosed with a gynecologic cancer, contributing to nearly 115,000 new cases annually. https://mma.prnewswire.com/media/2765906/FWC_Race_To_End_Women_s_Cancer.jpg September is Gynecologic Cancer Awareness Month and the Foundation for Women's Cancer (FWC) invites you to take action and raise your voice at the 2025 Race to End Women's Cancer, held on Sunday,
The following issues have been halted by CIRO: Company: Sol Strategies Inc. CSE Symbol: HODL All Issues: No Reason: Single Stock Circuit Breaker Halt Time (ET): 2:29:27 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a
(NASDAQ:REPL), SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) — Replimune Group Inc. (NASDAQ: REPL) is under fire from investors following a dramatic regulatory setback that sent its stock into freefall. A newly filed securities class action accuses the biotech firm and its leadership of concealing critical risks tied to its flagship cancer therapy, RP1, and
Replimune (REPL) Faces Investor Lawsuit After FDA Blocks Cancer Drug Approval – Hagens Berman REPL Investors with Losses Encouraged to Contact the Firm GlobeNewswire September 05, 2025 SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) — Replimune Group Inc. (NASDAQ: REPL) is under fire from investors following a dramatic regulatory setback that sent its stock into
NEW YORK, NY / ACCESS Newswire / September 5, 2025 / If you suffered a loss on your Lockheed Martin Corporation (NYSE:LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lockheed-martin-corporation-lawsuit-submission-form?prid=165645&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / September 5, 2025 / – SueWallSt: Class Action Filed Against Lineage, Inc. – Contact Levi & Korsinsky This lawsuit is on behalf of all purchasers of Lineage common stock in or traceable to the registration statement used in connection with the Company’s July 26, 2024 initial public offering.
NEW YORK, NY / ACCESS Newswire / September 5, 2025 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/altimmune-inc-lawsuit-submission-form-2?prid=165642&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call